Sensex
83,184.80 profit arw 236.57 (0.29%)
Nifty
25,415.80 profit arw 38.25 (0.15%)
Nasdaq
17,573.30 profit arw -54.76 (-0.31%)

GET IN TOUCH

GET IN TOUCH

IPO Details


Entero Healthcare Solutions Ltd
Registered Office: Plot # I-35 Bldg-B Ind. Area, Phase-I 13/7 Mathura Road, Faridabad - 121003, Haryana
Phone: 0129-4877300
Email: jayant.prakash@enterohealthcare.com
Website: www.enterohealthcare.com
Initial public offering of 12,725,244# equity shares of face value of Rs. 10 each (Equity) of Entero Healthcare Solutions Limited (The Company or the Issuer) for cash at a price of Rs. 1,258 per equity share including a share premium of Rs. 1,248 per equity share (the Offer Price) aggregating to Rs. 1600.00# crores (the Offer). The offer comprises of a fresh issue of 7,955,769# equity shares by the company aggregating to Rs. 1000.00# crores (the Fresh Issue) and an offer for sale of 4,769,475# equity shares (the Offered Shares) aggregating to Rs. 600.00# crores (the Offer for Sale), comprising of 470,210# equity shares aggregating to Rs. 59.15# crores by Prabhat Agrawal, 313,472# equity shares aggregating to Rs. 39.44# crores by Prem Sethi, 3,815,580# equity shares aggregating to Rs. 480.00# crores by Orbimed Asia iii Mauritius Limited, 4,401# equity shares aggregating to Rs. 0.55# crores by Chethan M.P., 1,320# equity shares aggregating to Rs. 0.17# crores by Deepesh T. Gala, 8,802# equity shares aggregating to Rs. 1.11# crores by Hemant Jose Barros, 4,401# equity shares aggregating to Rs. 0.55# crores by Hemant Jaggi, 2,201# equity shares aggregating to Rs. 0.28# crores by K.R.V.S. Varaprasad, 39,610# equity shares aggregating to Rs. 4.98# crores by K.E. Prakash, 1,320# equity shares aggregating to Rs. 0.17# crores by Lavu Sahadev, 12,103# equity shares aggregating to Rs. 1.52# crores by Manoj K Sanghani, 8,802# equity shares aggregating to Rs. 1.11# crores by Millennium Medicare Private Limited, 2,201# equity shares aggregating to Rs. 0.28# crores by K. Naveen Kumar Gupta, 42,250# equity shares aggregating to Rs. 5.32# crores by Novacare Drug Specialities Private Limited, 15,074# equity shares aggregating to Rs. 1.90# crores by Petros Diamantides, 13,203# equity shares aggregating to Rs. 1.66# crores by Prashanth Ravindrakumar, 1,102# equity shares aggregating to Rs. 0.14# crores by Suraj Prakash Atreja, 1,320# equity shares aggregating to Rs. 0.17# crores by Venkata Ramana Siva Kumar Yanamadala, 12,103# equity shares aggregating to Rs. 1.52# crores by Vikramaditya Ambre (collectively the Selling Shareholders) (the Offer for Sale, and together with the fresh issue, the Offer). The offer will constitute 29.25%# of the post-offer paid-up equity share capital of the company. The offer included a reservation of 70,237# equity shares, aggregating to Rs. 8.00# crores (constituting 0.16%# of the post-offer paid-up equity share capital), for subscription by eligible employees (Employee Reservation Portion). The offer less the employee reservation portion is hereinafter referred to as the Net Offer. The offer and the net offer constitute 29.25%# and 29.09%#, respectively, of the post-offer paid-up equity share capital of the company. The company, in consultation with the book running lead managers, offered a discount of 9.46% to the offer price to eligible employees bidding in the employee reservation portion (Employee Discount). #Subject to finalisation of basis of allotment The face value of equity shares is Rs. 10 each. The offer price is 125.80 times the face value of the equity shares.
Issue Money Payable On
Opens On Closes On Application Allotment
09-Feb-2024 13-Feb-2024 1,258.00 0.00
Minimum Application for shares in Nos : 11 Further Multiples of : 11
()Cr. Lead Managers to the Issue
Project Cost 951.20 Dam Capital Advisors Ltd
Project Financed through Current Offer 1,600.00
Post Issue Equity Share Capital 43.50
Issue Price 1,258.00
Projects
Repayment/prepayment in full or part of certain borrowings availed by the company and its subsidiaries
Funding the long term working capital requirements
General corporate purposes
Pursuing inorganic growth intiatives through acquisitions
Promoted By
Prabhat Agrawal
Prem Sethi
Orbimed Asia III Mauritius Ltd
Listing At
BSE
NSE
Registrar to the Issue
Link Intime India Pvt Ltd

INDIAN INDICES

Sensex

83,184.80 236.57 (0.29%)

Nifty

25,415.80 38.25 (0.15%)

GLOBAL INDICES

USD

83.95 -0.07 (-0.08%)

NASDAQ

17,573.30 -54.76 (-0.31%)

HANG SENG

18013.16 353.14(2.00%)